Instrument Inactif

Autres langues IntelliCentrics Global Holdings Ltd.

Actions

6819

KYG480041089

Equipement et technologie médicale avancés

Autres langues

02/05/24	Intellicentrics Declares Special Interim Dividend
25/04/24	IntelliCentrics Global Holdings Ltd. Announces Special Interim Dividend, Payable on May 3, 2024
28/03/24	Intellicentrics Global Holdings Ltd. Proposes Special Dividend, Payable on or Before May 7, 2024
04/03/24	IntelliCentrics Global Delays Circular Dispatch for Sale of UK Wing
01/03/24	IntelliCentrics Global Holdings' Fiscal H1 Loss Widens
29/02/24	IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2023
12/02/24	IntelliCentrics Arm to Sell UK Business for $246 Million
29/09/23	IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023
01/03/23	IntelliCentrics Global's July-December 2022 Loss Narrows
28/02/23	IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2022
20/02/23	IntelliCentrics Global Holdings Ltd. Appoints Liao Xiaoxin as Independent Non-Executive Director and Member of Audit Committee and Nomination Committee
30/11/22	IntelliCentrics Global Holdings Ltd. Announces Executive Changes
30/09/22	IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Full Year Ended June 30, 2022
25/05/22	IntelliCentrics’ Innovations Help Drive Advanced Dallas Hospital & Clinics’ Mission of Delivering Leading Edge Medicine and Personalized Patient Care
24/05/22	IntelliCentrics enters into Strategic Alliance with Taiwanese Health Insurance Providers
28/02/22	Tranche Update on IntelliCentrics Global Holdings Ltd.'s Equity Buyback Plan announced on December 10, 2021.
28/02/22	Tranche Update on IntelliCentrics Global Holdings Ltd.'s Equity Buyback Plan announced on October 29, 2021.
28/02/22	IntelliCentrics Global Holdings Ltd. Reports Earnings Results for the Half Year Ended December 31, 2021
24/01/22	IntelliCentrics Global Projects Wider Loss in Fiscal H1
24/01/22	IntelliCentrics Global Holdings Ltd. Provides Earnings Guidance for the Six Months Ended December 31, 2021
10/12/21	IntelliCentrics Global Holdings Ltd. commences an Equity Buyback Plan for 45,495,215 shares, representing 10% of its issued share capital, under the authorization approved on December 10, 2021.
10/12/21	IntelliCentrics Global Holdings Ltd.'s Equity Buyback announced on October 29, 2021, has expired with 2,165,000 shares, representing 0.47% for $1.91 million
03/12/21	IntelliCentrics and RepScrubs? Announce Partnership Using ?Trust as a Technology? to Deliver Vendor Compliance that Lowers Costs for Healthcare Facilities
15/11/21	Milestone Surgery Center Joins IntelliCentrics?s SEC?URE Ethos to Accelerate Physician Onboarding for Planned Growth
08/11/21	IntelliCentrics and EUCARE Announces Strategic Partnership Supporting Delivery of Taiwan?s High-Quality, Integrated Medical Services to the World